Global Minimally Invasive Surgery Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Monitoring & Visualization Systems, Surgical Devices, Endosurgical Equipment, Electrosurgical Equipment, and Laparoscopy Devices.By Technology Analysis;
Laparoscopy Surgery, Transcatheter Surgery, Medical Robotics, and Non-Visual Imaging.By Application;
Gastrointestinal Surgery, Urulogy Surgery, Gyneculogy Surgery, Thoracic Surgery, Cosmetic Surgery, Orthopedic & Spine Surgery, Vascular Surgery, Breast Surgery, Bariatric Surgery, Adrenalectomy Surgery, Cardiac Surgery, Cancer Surgery, Anti-Reflux Surgery, Culectomy Surgery, Ear, Nose & Throat Surgery, Culon & Rectal Surgery, and Obesity Surgery.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Minimally Invasive Surgery Market (USD Million), 2021 - 2031
In the year 2024, the Global Minimally Invasive Surgery Market was valued at USD 41,577.49 million. The size of this market is expected to increase to USD 67,422.29 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.2%.
The Global Minimally Invasive Surgery (MIS) Market is experiencing unprecedented growth, driven by the increasing demand for surgical procedures that offer significant advantages over traditional open surgeries. Minimally invasive surgery encompasses a range of techniques designed to minimize tissue damage, reduce postoperative pain, shorten hospital stays, and accelerate patient recovery times. These benefits have led to a transformative shift in surgical practice, with MIS becoming the preferred approach for a variety of procedures across multiple medical disciplines.
Technological advancements are at the forefront of this market expansion. Innovations in imaging technologies, surgical instruments, and robotic systems have enhanced the precision, safety, and efficacy of minimally invasive procedures. These advancements not only improve patient outcomes but also expand the range of conditions that can be treated using minimally invasive techniques. As a result, the adoption of MIS is rapidly increasing in fields such as gynecology, orthopedics, cardiology, urology, and general surgery.
The growing prevalence of chronic diseases, an aging global population, and rising healthcare costs are significant factors propelling the demand for minimally invasive surgical solutions. Patients and healthcare providers alike are increasingly seeking options that offer less invasive alternatives to conventional surgery, which often involve longer recovery times and greater risk of complications. Additionally, the shift towards value-based healthcare models emphasizes the importance of cost-effective treatments that deliver high-quality outcomes, further supporting the adoption of MIS.
Global Minimally Invasive Surgery Market Recent Developments
-
In May 2024, Intuitive received FDA clearance for its fifth-generation robotic system, the da Vinci 5. This advanced surgical technology was designed to enhance precision and efficiency in minimally invasive procedures, building on the success of previous generations of the da Vinci system.
-
In January 2024, Boston Scientific Corporation entered into an agreement to acquire Axonics, Inc., enabling the company to enter the sacral neuromodulation market. This strategic move opened opportunities for expanding patient access to care in a high-growth segment.
Segment Analysis
This report extensively covers different segments of Global Minimally Invasive Surgery Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
The Global Minimally Invasive Surgery (MIS) Market is comprehensively segmented to provide a detailed understanding of its diverse components and dynamics. One primary segmentation is by product, which includes a wide range of surgical instruments, accessories, and devices used in minimally invasive procedures. This category encompasses endoscopes, laparoscopic instruments, robotic-assisted surgical systems, and other specialized tools that facilitate precise and less invasive surgeries.
Another critical segmentation is by technology analysis, which examines the various technological advancements driving the MIS market. Key technologies include laparoscopic surgery, endoscopic surgery, and robotic-assisted surgery, each offering unique benefits and applications. Laparoscopic and endoscopic technologies utilize small incisions and specialized cameras to perform surgeries with minimal tissue damage, while robotic-assisted surgery provides enhanced precision, dexterity, and control through robotic systems.
The segmentation by application highlights the broad and expanding use of minimally invasive techniques across different medical fields. Major applications include gynecology, orthopedics, cardiology, urology, and general surgery, among others. Each application area benefits from the reduced trauma and quicker recovery times associated with MIS, leading to increased adoption across various specialties.
Geographical segmentation of the Global MIS Market provides insights into regional variations in adoption, market size, and growth potential. Key regions include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Each region presents unique opportunities and challenges based on factors such as healthcare infrastructure, economic conditions, regulatory environments, and patient demographics.
Global Minimally Invasive Surgery Segment Analysis
In this report, the Global Minimally Invasive Surgery Market has been segmented by Product, Technology Analysis, Application, and Geography.
Global Minimally Invasive Surgery Market, Segmentation by Product
The Global Minimally Invasive Surgery Market has been segmented by Product into Monitoring & Visualization Systems, Surgical Devices, Endosurgical Equipment, Electrosurgical Equipment, and Laparoscopy Devices.
One of the primary product categories is Monitoring & Visualization Systems. These systems include advanced imaging technologies such as endoscopes, laparoscopes, and other visualization devices that enable surgeons to see inside the body with high precision. Real-time imaging and high-definition displays are critical for performing accurate and effective minimally invasive procedures, ensuring that surgeons can navigate and operate with minimal disruption to surrounding tissues.
Surgical Devices form another crucial segment of the MIS market. This category includes instruments such as scalpels, scissors, and forceps that are specifically designed for minimally invasive techniques. These devices are often smaller and more precise than traditional surgical tools, allowing for operations through tiny incisions. Innovations in this segment are focused on enhancing the precision, ergonomics, and functionality of the instruments to improve surgical outcomes and reduce patient recovery times.
The Endosurgical Equipment segment encompasses a range of devices used in endoscopic procedures, which involve the insertion of a flexible tube with a light and camera through a small incision or natural orifice. This equipment includes various endoscopes, graspers, scissors, and suturing devices that enable surgeons to perform complex procedures with minimal invasion. The development of endosurgical tools is driven by the need for increased versatility and reliability in accessing and treating internal organs.
Electrosurgical Equipment represents another vital component of the MIS market. These devices use electrical energy to cut, coagulate, desiccate, or fulgurate tissue. Electrosurgical tools, such as electric scalpels and coagulators, provide surgeons with precise control over bleeding and tissue dissection, which is essential for minimally invasive procedures. Advances in this segment focus on improving the safety, efficiency, and precision of electrosurgical techniques.
Laparoscopy Devices are integral to minimally invasive surgery, particularly in abdominal and pelvic surgeries. This segment includes laparoscopes, trocars, insufflators, and various laparoscopic instruments. Laparoscopy devices enable surgeons to perform diagnostic and therapeutic procedures with minimal incisions, reducing patient trauma and speeding up recovery. Continuous innovation in this segment aims to enhance the capabilities and ease of use of laparoscopic tools, making them more accessible and effective for a wide range of surgical applications.
Global Minimally Invasive Surgery Market, Segmentation by Technology Analysis
The Global Minimally Invasive Surgery Market has been segmented by Technology Analysis into Laparoscopy Surgery, Transcatheter Surgery, Medical Robotics, and Non-Visual Imaging.
One key segment is Laparoscopy Surgery, which involves the use of a laparoscope—a thin, flexible tube with a camera and light at the end—to perform surgeries through small incisions. Laparoscopic techniques are widely used in abdominal and pelvic surgeries, offering significant benefits such as reduced postoperative pain, shorter hospital stays, and faster recovery times. The ongoing development of more advanced laparoscopic instruments and imaging technologies continues to enhance the precision and safety of these procedures.
Transcatheter Surgery represents another critical technological segment within the MIS market. This approach involves performing surgeries through the vascular system using catheters, eliminating the need for large incisions. Transcatheter techniques are particularly prevalent in cardiology, such as in transcatheter aortic valve replacement (TAVR) and angioplasty. These procedures offer minimally invasive solutions for treating complex cardiovascular conditions, reducing the risk of complications and improving patient outcomes.
Medical Robotics is a rapidly growing segment in the MIS market, revolutionizing how surgeries are performed. Robotic-assisted surgical systems, such as the da Vinci Surgical System, provide surgeons with enhanced dexterity, precision, and control through robotic arms that can maneuver in ways that human hands cannot. These systems often incorporate high-definition 3D visualization and advanced instrumentation, allowing for more accurate and minimally invasive procedures. Medical robotics are expanding the scope and capabilities of minimally invasive surgeries, particularly in complex and delicate operations.
Non-Visual Imaging technologies encompass a range of modalities that provide critical information beyond what is visible to the naked eye. This includes ultrasound, MRI, CT scans, and fluoroscopy, which are used to guide minimally invasive procedures. Non-visual imaging is essential for preoperative planning, intraoperative navigation, and postoperative assessment, enabling surgeons to operate with greater accuracy and confidence. The integration of these imaging technologies with minimally invasive techniques enhances the overall effectiveness and safety of surgical interventions.
Global Minimally Invasive Surgery Market, Segmentation by Application
The Global Minimally Invasive Surgery Market has been segmented by Application into Gastrointestinal Surgery, Urulogy Surgery, Gyneculogy Surgery, Thoracic Surgery, Cosmetic Surgery, Orthopedic & Spine Surgery, Vascular Surgery, Breast Surgery, Bariatric Surgery, Adrenalectomy Surgery, Cardiac Surgery, Cancer Surgery, Anti-Reflux Surgery, Culectomy Surgery, Ear, Nose & Throat Surgery, Culon & Rectal Surgery, and Obesity Surgery.
One prominent application is Gastrointestinal Surgery, which includes procedures like appendectomies, cholecystectomies, and colorectal surgeries. Minimally invasive approaches in this field reduce recovery times and complications associated with traditional open surgeries. Urology Surgery is another key application area, encompassing procedures such as prostatectomies, nephrectomies, and treatments for kidney stones. The precision and reduced invasiveness of MIS techniques are particularly beneficial in this field, improving patient outcomes and reducing hospital stays.
Gynecology Surgery involves procedures like hysterectomies, myomectomies, and treatments for endometriosis. Minimally invasive gynecological surgeries offer significant advantages, including smaller incisions, less pain, and quicker recovery, which are highly valued by patients. Thoracic Surgery, which includes lung resections and esophageal surgeries, benefits greatly from minimally invasive techniques that reduce trauma to the chest cavity, leading to faster patient recovery and fewer complications.
Cosmetic Surgery is another application where MIS is widely used. Procedures such as liposuction, facelifts, and breast augmentations are performed using minimally invasive techniques to enhance cosmetic outcomes while minimizing scarring and downtime. Orthopedic & Spine Surgery encompasses minimally invasive procedures for joint replacements, spinal fusions, and arthroscopic surgeries. These techniques significantly reduce postoperative pain and rehabilitation time compared to traditional open surgeries.
Vascular Surgery involves the treatment of vascular diseases using minimally invasive methods like endovascular aneurysm repair (EVAR) and angioplasty. These techniques minimize surgical trauma and improve patient recovery rates. Breast Surgery, including lumpectomies and mastectomies, increasingly utilizes minimally invasive approaches to reduce scarring and preserve breast tissue, which is crucial for both aesthetic and psychological reasons.
Bariatric Surgery is performed to treat obesity and includes procedures like gastric bypass and sleeve gastrectomy. Minimally invasive bariatric surgeries offer significant benefits, including reduced recovery times and lower risks of complications. Adrenalectomy Surgery involves the removal of adrenal glands and benefits from minimally invasive techniques that reduce postoperative pain and hospital stays.
Cardiac Surgery, including procedures like valve repair and coronary artery bypass, increasingly employs minimally invasive methods to enhance patient outcomes and reduce recovery times. Cancer Surgery utilizes minimally invasive techniques to remove tumors with minimal damage to surrounding tissues, improving recovery and reducing postoperative complications.
Anti-Reflux Surgery, such as fundoplication for treating gastroesophageal reflux disease (GERD), benefits from minimally invasive approaches that offer quicker recovery and less postoperative discomfort. Colectomy Surgery involves the removal of all or part of the colon and is often performed using minimally invasive techniques to reduce recovery times and complications.
Ear, Nose & Throat (ENT) Surgery includes procedures like sinus surgeries, tonsillectomies, and ear tube placements, where minimally invasive methods improve precision and recovery. Colon & Rectal Surgery benefits from minimally invasive techniques for procedures like hemorrhoidectomies and colorectal cancer surgeries, reducing patient recovery times and complications.
Obesity Surgery involves various minimally invasive procedures aimed at weight loss and management, improving patient outcomes and reducing the risks associated with traditional open surgeries.
Global Minimally Invasive Surgery Market, Segmentation by Geography
In this report, the Global Minimally Invasive Surgery Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Minimally Invasive Surgery Market Share (%), by Geographical Region, 2024
North America represents a significant share of the MIS market, driven by advanced healthcare infrastructure, high adoption rates of new technologies, and substantial healthcare spending. The presence of leading medical device manufacturers and a strong emphasis on research and development further propel the market in this region. Additionally, the rising prevalence of chronic diseases and an aging population contribute to the growing demand for minimally invasive surgical procedures.
Europe is another major region in the MIS market, characterized by a well-established healthcare system and strong regulatory frameworks. Countries like Germany, France, and the UK are at the forefront of adopting minimally invasive techniques, supported by favorable reimbursement policies and increasing investments in healthcare technology. The focus on improving patient outcomes and reducing healthcare costs also drives the adoption of MIS across Europe.
Asia Pacific is experiencing rapid growth in the MIS market, fueled by increasing healthcare investments, improving healthcare infrastructure, and rising awareness about the benefits of minimally invasive surgeries. Countries such as China, India, and Japan are significant contributors to this growth, with expanding medical tourism, a large patient population, and a growing number of skilled healthcare professionals. The region's economic growth and increasing healthcare expenditure further support market expansion.
The Middle East and Africa region presents a mixed landscape for the MIS market. While there are challenges related to healthcare access and infrastructure in some areas, there is also significant potential for growth. Wealthier nations like the UAE and Saudi Arabia are investing heavily in healthcare advancements and are adopting minimally invasive techniques to improve patient care. Efforts to enhance healthcare infrastructure and increase medical training are expected to drive market growth in this region.
Latin America is another emerging market for minimally invasive surgery, with countries like Brazil, Mexico, and Argentina leading the way. The region's growing middle class, increasing healthcare expenditure, and rising awareness of advanced medical technologies contribute to the market's expansion. Additionally, initiatives to improve healthcare access and quality, along with the growing burden of chronic diseases, are driving the demand for minimally invasive surgical procedures.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Minimally Invasive Surgery Market. These factors include; Market Drivers, Restraints, and Opportunities.
Drivers:
- Rising glaucoma prevalence
- Demand surge for minimally invasive surgeries
- Aging population's susceptibility
-
Increased glaucoma awareness - Increased glaucoma awareness is a significant driver for the market. With growing educational campaigns and health initiatives, both patients and healthcare providers are becoming more informed about glaucoma, its risks, and the benefits of early diagnosis and treatment. Public health organizations and medical professionals are increasingly emphasizing the importance of regular eye check-ups, especially for high-risk groups such as the elderly and those with a family history of glaucoma. This heightened awareness is leading to earlier detection and intervention, which in turn drives the demand for advanced treatment options like MIGS devices.
Social media and online health platforms play a crucial role in spreading information about glaucoma. Influencers, health bloggers, and patient advocacy groups are actively sharing their experiences and knowledge about living with glaucoma, further increasing public awareness. The availability of more information is empowering patients to seek out innovative treatments and actively participate in their eye care management. As a result, there is a growing patient preference for minimally invasive procedures that promise effective results with fewer complications and faster recovery times compared to traditional surgeries.
Healthcare providers are also benefiting from increased awareness as it translates to a higher number of patients seeking consultations and treatments for glaucoma. This demand encourages ophthalmologists and eye care clinics to invest in and adopt the latest MIGS technologies to provide advanced care. Manufacturers of MIGS devices are witnessing an uptick in sales and are motivated to continue developing advanced solutions to meet the growing needs of an informed and proactive patient population.
Restraints:
- Surgeon training scarcity
- Regulatory hurdles for device approval
- Efficacy and safety concerns
-
Traditional treatment reluctance - Traditional treatment reluctance acts as a restraint for the market. Many patients and healthcare providers remain cautious about adopting new technologies and prefer to rely on conventional glaucoma treatments such as eye drops, laser therapy, and traditional surgical procedures. This hesitation is often due to a lack of familiarity with MIGS devices, concerns about their long-term efficacy, and potential risks associated with new surgical techniques.
There is often skepticism about the cost-effectiveness of MIGS procedures. Traditional treatments are generally well-understood and widely covered by insurance policies, whereas newer procedures might not be as comprehensively reimbursed. This financial uncertainty can deter both patients and practitioners from opting for minimally invasive solutions despite their potential benefits.
Additionally, some healthcare providers may lack the necessary training and expertise to perform MIGS procedures, leading to a preference for established methods they are more comfortable with. This resistance to change is compounded by the need for significant investment in new equipment and training, which can be a substantial barrier for smaller practices and clinics.
Opportunities:
- Integrated treatment protocols
- Value-based care adoption
- Patient education initiatives
-
Post-market surveillance enhancement - Post-market surveillance enhancement as an opportunity in the market can significantly contribute to the market's growth and acceptance. Improved post-market surveillance involves the systematic collection, analysis, and interpretation of data related to the performance and safety of MIGS devices after they have been approved and are in use. This can enhance the understanding of long-term outcomes, device effectiveness, and potential complications, thus building confidence among healthcare providers and patients.
Enhanced post-market surveillance can provide valuable insights that help refine surgical techniques, improve device designs, and identify best practices for patient selection and postoperative care. This ongoing monitoring can lead to the development of more robust clinical guidelines and training programs, thereby increasing the adoption rate of MIGS procedures.
Better surveillance can facilitate quicker identification and response to any adverse events or device malfunctions, ensuring patient safety and maintaining trust in these innovative treatments. It can also support regulatory compliance and help manufacturers demonstrate the continued efficacy and safety of their products, potentially leading to expanded indications and greater market penetration.
Competitive Landscape Analysis
Key players in Global Minimally Invasive Surgery Market include,
- Alcon, Inc.
- Glaukos Corporation.
- Johnson & Johnson Vision
- AbbVie Inc. (Allergan Plc.)
- Corza Ophthalmology
- Carl Zeiss Meditec AG
- Katalyst Surgical
- Lumenis Ltd
- Ziemer Ophthalmic Systems AG
- Iridex Corporation
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Technology Analysis
- Market Snapshot, By Application
- Market Snapshot, By Region
- Global Minimally Invasive Surgery Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising glaucoma prevalence
- Demand surge for minimally invasive surgeries
- Aging population's susceptibility
- Increased glaucoma awareness
- Restraints
- Surgeon training scarcity
- Regulatory hurdles for device approval
- Efficacy and safety concerns
- Traditional treatment reluctance
- Opportunities
- Integrated treatment protocols
- Value-based care adoption
- Patient education initiatives
- Post-market surveillance enhancement
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Minimally Invasive Surgery Market, By Product, 2021-2031 (USD Million)
- Monitoring & Visualization Systems
- Surgical Devices
- Endosurgical Equipment
- Electrosurgical Equipment
- Laparoscopy Devices
- Global Minimally Invasive Surgery Market, By Technology Analysis, 2021-2031 (USD Million)
- Laparoscopy Surgery
- Transcatheter Surgery
- Medical Robotics
- Non-Visual Imaging
- Global Minimally Invasive Surgery Market, By Application, 2021-2031 (USD Million)
- Gastrointestinal Surgery
- Urulogy Surgery
- Gyneculogy Surgery
- Thoracic Surgery
- Cosmetic Surgery
- Orthopedic & Spine Surgery
- Vascular Surgery
- Breast Surgery
- Bariatric Surgery
- Adrenalectomy Surgery
- Cardiac Surgery
- Cancer Surgery
- Anti-Reflux Surgery
- Culectomy Surgery
- Ear
- Nose & Throat Surgery
- Culon & Rectal Surgery
- Obesity Surgery
- Global Minimally Invasive Surgery Market, By Geography, 2021 -2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Minimally Invasive Surgery Market, By Product, 2021-2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Alcon, Inc.
- Glaukos Corporation.
- Johnson & Johnson Vision
- AbbVie Inc. (Allergan Plc.)
- Corza Ophthalmology
- Carl Zeiss Meditec AG
- Katalyst Surgical
- Lumenis Ltd
- Ziemer Ophthalmic Systems AG
- Iridex Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market